Catherine Sautès-Fridman Selected Research

Intraocular Lymphoma

1/2013	Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis.
7/2007	Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catherine Sautès-Fridman Research Topics

Disease

84	Neoplasms (Cancer) 01/2024 - 03/2002
10	Tertiary Lymphoid Structures 10/2023 - 03/2011
10	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 03/2015
8	Inflammation (Inflammations) 01/2022 - 04/2010
6	Melanoma (Melanoma, Malignant) 01/2023 - 11/2002
6	B-Cell Lymphoma (Lymphoma, B Cell) 05/2013 - 07/2007
5	Lung Neoplasms (Lung Cancer) 01/2021 - 04/2010
4	Carcinogenesis 01/2024 - 11/2012
4	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2011
3	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2002
3	Lymphoma (Lymphomas) 01/2016 - 01/2012
2	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 01/2020
2	Thrombotic Microangiopathies 01/2022 - 10/2012
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 10/2012
2	Disease Progression 01/2019 - 08/2017
2	Carcinoma (Carcinomatosis) 01/2019 - 09/2012
2	Obesity 07/2015 - 04/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2014 - 08/2012
2	Intraocular Lymphoma 01/2013 - 07/2007
2	Tuberculosis (Tuberculoses) 09/2012 - 08/2012
2	Infections 02/2011 - 05/2007
1	Heart Failure 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Liver Failure 01/2022
1	Digestive System Diseases 01/2022
1	Massive Hepatic Necrosis 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 10/2020
1	Microsatellite Instability 01/2020

Drug/Important Bio-Agent (IBA)

12	AntigensIBA 01/2023 - 10/2012
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
9	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2019
9	AntibodiesIBA 10/2023 - 12/2006
9	CytokinesIBA 01/2023 - 03/2002
8	Immunoglobulin G (IgG)IBA 10/2023 - 11/2002
8	VaccinesIBA 05/2015 - 08/2012
7	Monoclonal AntibodiesIBA 01/2024 - 01/2010
7	Complement System Proteins (Complement)IBA 01/2022 - 05/2007
6	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 12/2012
6	Antineoplastic Agents (Antineoplastics)IBA 04/2015 - 12/2012
6	Toll-Like Receptor AgonistsIBA 01/2014 - 08/2012
5	IpilimumabIBA 01/2023 - 10/2019
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2008
5	LigandsIBA 01/2019 - 04/2010
4	ChemokinesIBA 08/2016 - 01/2011
4	Imiquimod (Aldara)FDA LinkGeneric 01/2014 - 08/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 03/2012
3	Sunitinib (Sutent)FDA Link 01/2022 - 03/2015
3	NivolumabIBA 01/2022 - 10/2019
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2021 - 11/2002
3	Protein Subunit VaccinesIBA 04/2015 - 12/2012
3	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2013 - 01/2011
3	IgG Receptors (Fc gamma RI)IBA 01/2010 - 11/2002
3	Neoplasm AntibodiesIBA 12/2008 - 11/2002
2	AutoantibodiesIBA 01/2024 - 10/2012
2	AutoantigensIBA 01/2024 - 01/2023
2	Immunoglobulin A (IgA)IBA 10/2023 - 01/2022
2	guadecitabineIBA 01/2023 - 12/2019
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 03/2015
2	Complement C1q (C1q Complement)IBA 01/2022 - 01/2019
2	ParaffinIBA 01/2021 - 01/2006
2	Complement Factor H (Factor H)IBA 01/2021 - 10/2012
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2017 - 05/2012
2	Messenger RNA (mRNA)IBA 08/2017 - 01/2011
2	Peptides (Polypeptides)IBA 04/2015 - 12/2012
2	monophosphoryl lipid AIBA 01/2014 - 08/2013
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2014 - 03/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 03/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014 - 03/2012
2	Interleukin-17 (Interleukin 17)IBA 01/2011 - 03/2002
2	Protein Isoforms (Isoforms)IBA 12/2008 - 12/2006
1	TrabectedinIBA 01/2024
1	Mannose ReceptorIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	AnaphylatoxinsIBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2021
1	Complement C1s (C1 Esterase)IBA 01/2021
1	EnzymesIBA 01/2021
1	dehydroacetic acid (DHAS)IBA 12/2019
1	atezolizumabIBA 10/2019
1	Bevacizumab (Avastin)FDA Link 10/2019
1	Complement C5a (Complement 5a)IBA 01/2019
1	AndrogensIBA 01/2019
1	Immune Checkpoint ProteinsIBA 01/2019
1	CalreticulinIBA 01/2016
1	Insulin (Novolin)FDA Link 07/2015

Therapy/Procedure

34	Therapeutics 01/2024 - 11/2002
23	Immunotherapy 10/2023 - 04/2010
5	Precision Medicine 01/2020 - 08/2015
3	Drug Therapy (Chemotherapy) 01/2024 - 03/2011
2	Radiotherapy 01/2024 - 09/2013
2	Biological Therapy 05/2016 - 03/2012
2	Oncolytic Virotherapy 02/2016 - 06/2013
1	Immunomodulation 01/2023
1	Prostatectomy (Retropubic Prostatectomy) 01/2019
1	Nephrectomy 08/2017